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Ultra-weak photon emission as 
a dynamic tool for monitoring 
oxidative stress metabolism
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Winden1, Kateřina Červinková3,4, Rawi Ramautar1, Eduard P. A. Van Wijk2, Michal Cifra  3, 
Ruud Berger1, Thomas Hankemeier1 & Jan van der Greef1,2
In recent years, excessive oxidative metabolism has been reported as a critical determinant of 
pathogenicity in many diseases. The advent of a simple tool that can provide a physiological readout of 
oxidative stress would be a major step towards monitoring this dynamic process in biological systems, 
while also improving our understanding of this process. Ultra-weak photon emission (UPE) has been 
proposed as a potential tool for measuring oxidative processes due to the association between UPE and 
reactive oxygen species. Here, we used HL-60 cells as an in vitro model to test the potential of using 
UPE as readout for dynamically monitoring oxidative stress after inducing respiratory burst. In addition, 
to probe for possible changes in oxidative metabolism, we performed targeted metabolomics on cell 
extracts and culture medium. Lastly, we tested the effects of treating cells with the NADPH oxidase 
inhibitor diphenyleneiodonium chloride (DPI). Our results show that UPE can be used as readout for 
measuring oxidative stress metabolism and related processes.
Respiratory burst is one of the first defence mechanisms used by specialised cells such as neutrophils in response 
to invading pathogens1–3. This process uses the rapid consumption of molecular oxygen (O2) to produce high 
levels of intracellular reactive oxygen species (ROS) for killing invading pathogens1–3. Under homeostatic condi-
tions, ROS are produced by mitochondria as a product of cellular metabolism4; however, during respiratory burst 
NADPH oxidase plays a central role in ROS production for cellular defence5, 6. The primary function of NADPH 
oxidase is the production of superoxide radicals (O2·−)7, 8, which serve as the initial substrate in the generation of 
a diverse variety of ROS species, including hydrogen peroxide (H2O2) and hydroxyl radicals (OH·).
Physiologically, ROS have a hormetic effect ‒ at relatively low concentrations, ROS have beneficial properties, 
which include maintaining cellular redox biology and facilitating signalling9, whereas at high concentrations, 
ROS cause oxidative stress that can damage nucleic acids, proteins, and lipids. Studies have shown that oxidative 
stress contributes to the pathogenesis of many diseases and conditions, including chronic inflammation10, vari-
ous types of cancers11, Alzheimer’s disease12, and cardiovascular disease13. Moreover, the aforementioned studies 
revealed a clear association between ROS production and NADPH oxidase, thereby providing insight into the 
underlying ROS-based physiological processes. In recent years, several NADPH inhibitors have been investigated 
as candidate therapies for ROS-related pathology14, 15, and measuring these oxidation reactions and related bio-
molecules can provide a readout of cellular oxidative stress16. ROS production has been analysed using various 
techniques, including photometry, luminometry, flow cytometry, and precipitation reactions17. However, all of 
these techniques provide a measure at only a single time point or require labels; moreover, these techniques are 
cell-dependent, laborious, and not necessarily feasible for diagnostic purposes. In contrast, ultra-weak photon 
emission (UPE) is a promising new tool that could be used to monitor oxidative processes. Indeed, the feasibility 
of using UPE as a tool for monitoring health and disease has been examined in several studies18–20.
Ultra-weak photons are emitted spontaneously by many biological systems21, 22. UPE is characterised as 
non-thermal radiation in the near-ultraviolet to visible region (100–800 nm) of the electromagnetic spectrum, 
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possibly reaching the near-infrared region (801–1300 nm). UPE is generated by the transition of electrons from 
an excited state to the ground state; excited electron states (e.g. triplet carbonyls, singlet oxygen, etc.) are pro-
duced by the oxidation of biomolecules by ROS21, 23. Thus, UPE is a potential new tool for monitoring dynamic 
biological processes that involve ROS, including ROS-related diseases24, 25, as well as processes related to oxidative 
stress metabolism. A clear advantage of UPE is that it provides spatiotemporal information; in addition, UPE is 
non-damaging, non-invasive, label-free, and relatively cost-effective.
Because UPE can reflect complex molecular processes, it can be combined with other technologies such as 
metabolomics, thereby providing valuable insight into the biochemical processes probed using UPE26. Recently, 
we used metabolomics to identify several metabolites correlated with UPE27. Moreover, metabolomics is a pow-
erful approach that can be applied to numerous biological studies due to the ability to detect many hundreds 
of metabolites in a single biological sample, thereby providing a ‘phenotypic’ readout of other ‘omics’. Previous 
reports suggest that lipid peroxidation of linoleic acid in cell membranes can strongly affect UPE emission18, 28. 
In this respect, the products of lipid and protein oxidation are closely related to UPE. For example, compounds 
related to the arachidonic acid pathway (e.g. isoprostanes, prostaglandins, and lysosphingolipids) are key signal-
ling compounds in biological systems and are often related to oxidative stress and/or inflammatory processes29, 30. 
In addition, previous studies demonstrated the relationship between these metabolites and low-level chemilumi-
nescence and electronically excited species31–34.
Here, we evaluated the feasibility of using UPE as a dynamic tool for monitoring oxidative stress metabolism 
and related processes. A metabolomics approach was also used to gain insight into the biochemical processes 
probed using UPE. We used differentiated neutrophil-like HL-60 cells as an in vitro model. Respiratory burst 
was induced by treating the cells with phorbol 12-myristate 13-acetate (PMA)35, 36; in response to PMA, these 
cells produce large quantities of ROS, which were monitored in real-time using UPE. A targeted metabolomics 
approach was then used to analyse metabolites related to oxidative stress and inflammation (e.g. prostaglandins 
and isoprostanes) in HL-60 cell extracts and culture medium. Moreover, we measured the effects of treating cells 
with the NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI).
Results
Ultra-weak photon emission (UPE). HL-60 cells were differentiated into neutrophil-like cells by incu-
bation in all-trans retinoic acid (ATRA) for up to 7 days. Next, we induced respiratory burst by treating the cells 
with PMA. After PMA induction we measured the dynamic UPE profile for 9000 seconds (Fig. 1). Figure 1A 
shows control experiments recorded under the same conditions and Fig. 1B presents the UPE profile of differ-
entiated cells on Day 7 induced by PMA in the presence or absence of DPI. Figure 1C illustrates the paired t-test 
performed (n = 5).
Cells treated with ATRA for only 2 days had no response to PMA stimulation. In contrast, cells treated with 
ATRA for 7 days had a robust increase in UPE in response to PMA due to a high amount of ROS generated. This 
profile is in agreement with our previous work27. Treating the differentiated cells with the NADPH oxidase inhib-
itor DPI significantly reduced (p < 0.0001) the UPE response, substantiating the biochemical link between ROS 
and UPE. Furthermore, this inhibition was also observed in undifferentiated cells (see Fig. 1A) due to a small 
percentage of cells spontaneously differentiating into neutrophils-like cells27.
Metabolic profiling of isoprostanes, prostaglandins and lysosphingolipids. Next, to measure 
the biochemical changes related to oxidative metabolism, we performed targeted metabolomics of compounds 
related to oxidative stress and inflammation, including prostaglandins, isoprostanes, nitro-fatty acids, and lysos-
phingolipids. We used our previously reported approach27 (see also Figure S1), and DPI treatment was included 
in order to determine which metabolic pathways may be involved in this process.
Based on the dynamic UPE profiles (see Fig. 1B and Figure S1), cell lysates (to measure intracellular metab-
olites) and culture medium samples (to measure extracellular metabolites) were obtained at four time points 
Figure 1. Dynamic UPE measurement of HL-60 cells treated with ATRA for 2 or 7 days to differentiate the 
cells into neutrophil-like cells. The lines (red - differentiated cells and black - undifferentiated cells) represent 
the moving UPE average of 100 points. (A) Control measurements. (B) The UPE profile of differentiated cells 
(day 7) was recorded after stimulation with PMA in the absence or presence of DPI. (C) Summary of peak UPE 
intensity measured in HL-60 cell treated for 7 days with ATRA after stimulation with PMA in the absence or 
presence of DPI. The data are represented as the mean ± SD (n = 5) of the normalized maximum peak intensity. 
Student’s paired t-test with ****p < 0.0001.
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relative to PMA stimulation and analysed using targeted metabolomics. TP1 corresponds to the basal condition 
(i.e. prior to the addition of PMA), and TP2, TP3 and TP4 correspond to 60, 4500 and 9000 seconds after PMA 
stimulation, respectively. To measure the metabolic profiles indicative of oxidative stress and inflammation, we 
used a custom-built liquid chromatography‒mass spectrometry platform37. A total of 10 and 11 metabolites were 
detected in the cell lysates and culture medium samples, respectively; 7 metabolites were detected in both samples 
(Table S1).
Intracellular metabolites. Among the 10 intracellular metabolites measured in the cell lysates, only 8-iso-PGE2, 
8-iso-PGE1, PGE1 and sphinganine C18:0 increased significantly in response to PMA stimulation, and sphin-
gosine C18:1 significantly decreased in response to PMA stimulation shown in Fig. 2 and Table S2. PGE2 did dis-
play an increasing trend over the four time points. We also found a significant correlation between the recorded 
UPE data and the metabolites measured (see Table S2).
Pre-treating the cells with DPI significantly decreased the PMA-induced responses of 8-iso-PGE2, 8-iso-PGE1 
and PGE1. In addition, the PMA-induced response of sphingosine increased, whereas sphinganine C18:0 had no 
response (see Fig. 2).
Extracellular metabolites. Next, we examined the extracellular metabolites measured from the culture medium 
during PMA-induced respiratory burst. Among the 11 compounds detected (see Table S1), only PGE2, PGD2, 
(±)5-iPF2α-IV, and 8-12-iPF2α-IV increased significantly during respiratory burst (Fig. 3 and Table S3). 
Interestingly, treating the cells with DPI also increased the extracellular levels of all four compounds. Spearman’s 
correlation showed a high correlation coefficient (r > 0.6) to the extracellular metabolite levels and the measured 
UPE intensity. However, the p-values were not significant (p > 0.05).
Discussion
Treating HL-60 cells with ATRA causes the cells to differentiate into neutrophil-like cells35. Neutrophils are spe-
cialised cells capable of producing high amounts of ROS. In addition, the differentiation of HL-60 cells into 
neutrophil-like cells is associated with morphological changes, as well as metabolic changes that occur at the cell 
surface and in the nucleus35, 38, 39. We used PMA to induce respiratory burst, thereby activating protein kinase 
C (PKC). PKC phosphorylates the cytosolic NADPH oxidase subunit p47PHOX, contributing to assembly of the 
NADPH oxidase complex40–42. The function of NADPH oxidase is to extract electrons from NADPH, transferring 
the electrons to oxygen, thereby forming O2·− in the cytosol and extracellular space; this ultimately leads to the 
generation of other ROS species5–7. Here, we found that UPE can be used to establish the link between respiratory 
burst and increased levels of ROS in response to PMA stimulation (Fig. 4).
The NADPH oxidase inhibitor DPI binds specifically to the flavoprotein subunit (a polypeptide in the plasma 
membrane - cytochrome b558), thereby blocking the flow of electrons in the NADPH oxidase complex5, 6, 43–45. DPI 
has also been used to inhibit mitochondrial ROS production46. In our study, DPI significantly decreased the UPE 
Figure 2. HL-60 cells were treated with ATRA for 7 days, after which respiratory burst was induced with PMA 
in the presence or absence of DPI. Cell lysates were collected at the indicated time points, and intracellular 
metabolites were measured. We performed intragroup ANOVA analysis over the four time points to identify 
significant changes in metabolite levels. Data are plotted as the mean ± SD (n = 3). ANOVA with *p < 0.05, 
**p < 0.01, ***p < 0.001, and ****p < 0.0001.
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signal in PMA-stimulated differentiated HL-60 cells. Interestingly, DPI also acts by suppressing O2·− production, 
H2O2 production, and mitochondrial processes such as NADH-ubiquinone oxidoreductase (complex I)43, 44, 46  
(see Fig. 4). In our study, we used DPI at its reported IC50 value(0.9 µM)44. At this concentration, DPI caused a 
50–60% decrease in the UPE signal, suggesting residual electron transport flow, likely due to residual NADPH 
oxidase activity and the relatively low levels of photon emissions from mitochondrial activity.
With respect to intracellular metabolites, isoprostanes such as 8-iso-PGE2 and 8-iso-PGE1 are non-enzymatic 
products produced by the auto-oxidation of arachidonic acid by free radicals; thus, these metabolites are useful 
markers of oxidative stress30. In biological processes involving ROS, polyunsaturated fatty acids (PUFAs) ‒ par-
ticularly arachidonic acid ‒ are susceptible to oxidation by free radicals. PUFAs also serve as a precursor for 
cyclooxygenase-mediated oxidation, producing thromboxanes, prostacyclins, and prostaglandins30, 47, 48.
Although the production of the isoprostane 8-iso-PGE1 is poorly understood, one study reported that 
E1-isoprostane is produced in plants by oxidation, with α-linoleic acid as the substrate49. Similarly, little is known 
regarding the production and biological role of 8-iso-PGE2. In a previous in vivo study with rats, 8-iso-PGE2 was 
identified as a non-enzymatic product of free radical‒catalysed lipid peroxidation, ultimately exerting potent 
biological activity (in this case, renal vasoconstriction)50. Another biological role of 8-iso-PGE2 is the ability to 
inhibit platelet aggregation51. Thus, 8-iso-PGE2 appears to act as a signalling molecule with a wide range of bio-
logical functions.
The prostaglandins PGE1 and PGE2 have been well characterised and mediate a variety of biological processes, 
including vasodilation52, platelet aggregation53, and adaptive crosstalk activation54. Here, we found that the intra-
cellular levels of both 8-iso-PGE2 and 8-iso-PGE1 are increased during respiratory burst in differentiated HL-60 
cells; therefore, these metabolites are presumably products of ROS oxidation mediated by NADPH oxidase and 
mitochondrial electron transport. Moreover, pre-treating cells with DPI significantly reduced the intracellular 
levels of isoprostanes and prostaglandins (see Fig. 2). Taken together, our results show that DPI treatment signifi-
cantly decreases the intracellular levels of 8-iso-PGE1, 8-iso-PGE2, and PGE1, thereby showing a clear correlation 
with UPE intensity.
Sphingosine and sphinganine are lysosphingolipids that serve as precursors for ceramide and/or 
sphingosine-1-phosphate, both of which are involved in various signalling pathways, including cell proliferation, 
differentiation, and apoptosis55. In addition, both sphingosine and sphinganine can inhibit PKC activity56, 57 (see 
Fig. 4). PKC phosphorylates p47PHOX, a key component of NADPH oxidase (see Fig. 4), and therefore contributes 
to the activation of respiratory burst by inducing flavoenzyme (cytochrome b558)44. Our finding of increased 
levels of sphinganine, however, suggests that PKC activity has an inhibitory role, acting as a negative regulator 
Figure 3. HL-60 cells were treated with ATRA for 7 days, after which respiratory burst was induced with PMA 
in the presence or absence of DPI. Culture medium was collected at the indicated time points, and extracellular 
metabolites were measured. We performed intragroup ANOVA analysis over the four time points to identify 
significant changes in metabolite levels. Data are plotted as the mean ± SD (n = 3/group). ANOVA with 
**p < 0.01 and ****p < 0.0001. The data points indicated with an “x” in the top-right panel were below the 
metabolite’s limit of detection.
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of respiratory burst. During respiratory burst, sphingosine C18:1 decreased significantly (see Fig. 2). Previous 
studies found that sphingosine is converted to N,N-dimethyl sphingosine (DMS), which has an even stronger 
inhibitory effect on PKC58. This may explain the decrease in sphingosine C18:1; however, DMS was not included 
in our analysis.
E-series prostaglandins play a role in cell signalling by activating E2 and E4 prostanoid receptors located on 
the neutrophils47. In a negative feedback mechanism, receptor E2 and E4 activation increases intracellular levels 
of cAMP inhibiting neutrophil extracellular traps59 and the respiratory burst60. This may explain the increased 
extracellular levels of E-series prostaglandins, including PGE2 as a protective mechanism.
PGD2 has both pro-inflammatory and anti-inflammatory properties and is considered one of the major media-
tors of the mast cell allergic response and can serve as a potent eosinophil chemoattractant61, 62. During respiratory 
burst, PGD2 is rapidly metabolised through enzymatic and non-enzymatic pathways to 11-epi-PGF2α, dihydro-
15-keto-PGD2, and PGJ2 in order to attract eosinophils to inflammatory sites61. However, PGJ2 was not included 
Figure 4. Schematic overview of the biological events involved in NADPH oxidase during PMA-induced 
respiratory burst in differentiated HL-60 cells. PMA activates protein kinase C (PKC), which signals to the 
nucleus, activating cyclooxygenase (COX) and phospholipase A2 (PLA2) pathways, leading to the production 
of prostaglandins. O2.−is first produced by NADPH oxidase as a primary ROS and is subsequently dismutated 
to H2O2 by superoxide dismutase (SOD). Thus, H2O2 serves as a substrate for generating hydroxyl radicals 
(OH•) via the Fenton reaction. Hydroxyl radicals (OH•) are potent oxidants that can produce the initial radical 
(R•) form of a wide range of biomolecules, including lipids, proteins, and nucleic acids. Via this mechanism, 
molecular oxygen is added to produce a peroxyl radical (ROO•), followed by cyclisation to produce dioxetane 
(ROOR) and decomposition to produce triplet excited carbonyl23. Alternatively, two ROO• moieties can 
recombine to form tetroxide (ROOOOR), which can decompose to form triplet excited carbonyl or singlet 
oxygen via the Russel reaction23. These electron-excited species emit photons, giving rise to UPE23. Eventually, 
intracellular ROS can react with biomolecules in the cell membrane (i.e. lipid peroxidation), giving rise to 
isoprostanes. Treating differentiated HL-60 cells with DPI, which binds to the NADPH oxidase complex, 
partially inhibits ROS production, decreases UPE emission, and decreases the levels of prostaglandins and 
isoprostanes. This figure was drawn by the first author R.C.R. Burgos using the software Adobe Illustrator and 
the image bank of Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons 
Attribution 3.0 Unported License. https://creativecommons.org/licenses/by/3.0/.
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among the metabolites analysed in the current study. Thus, PGD2 may be produced during respiratory burst in 
order to attract other immune cells (e.g. eosinophils), thereby further stimulating the immune response at the site 
of inflammation. We hypothesise that ROS generated by NADPH oxidase during respiratory burst induces lipid 
peroxidation in the cell membrane. Thus, prostaglandins and isoprostanes are secreted into the extracellular space 
during membrane repair (see Fig. 4). Although our analysis revealed significant PMA-induced changes in PGE2, 
PGD2, (±)5-iPF2α-IV, and 8-12-iPF2α-IV in the medium, DPI had the same effect, with slightly increased levels.
Taken together, these results suggest that UPE is correlated only with intracellular signalling metabolic inter-
mediates. These findings strongly support the notion that UPE is linked to intracellular metabolism. Another 
explanation for the results of our analysis of extracellular metabolites is that the time course of respiratory burst 
(measured up to 9000 seconds) was too short for studying the flow of metabolites from the cytoplasm to the 
extracellular medium.
In summary, we report a strong correlation between ultra-weak photon emission intensity, NADPH oxidase 
activity and intracellular metabolism. The intracellular levels of the isoprostanes 8-iso-PGE1 and 8-iso-PGE2 
and the prostaglandin PGE1 significantly increased during PMA-induced respiratory burst, and DPI inhibited 
50–60% of the PMA-induced UPE signal. These results indicate that UPE can be used as a dynamic readout tool 
in combination with metabolomics to monitor oxidative metabolism in ROS-related physiological processes. 
Follow-up studies should focus on identifying the specific radical species using spin-trapping electron paramag-
netic resonance, which may also help identify the molecules that undergo oxidative damage. Optical spectral 
analysis of the UPE signal may also help identify the specific photon-emitting molecules.
Methods
Cell culture and experimental design. All experiments with human cell lines were performed in accord-
ance with approved guidelines, and all experimental protocols were approved in accordance with the regulations 
established by the Institute of Photonics and Electronics, Czech Academy of Sciences. The acute promyelocytic 
leukaemia cell line HL-60 (catalogue number CCL-240; lot number 62690063; ATCC, Manassas, VA) were cul-
tured in Iscove’s Modified Dulbecco’s Medium (IMDM) without phenol red (Gibco-Life Technologies, Grand 
Island, NY) supplemented with 10% (v/v) fetal calf serum and 1% (v/v) penicillin/streptomycin (Sigma-Aldrich, 
St. Louis, MO) in an incubator at 37 °C in 5% CO2. The cells were seeded at 2 × 105 cells/ml and maintained in 
the exponential growth phase in accordance with the instructions provided by ATCC. Cell number and viability 
were measured using the trypan blue exclusion method with an automated cell counter (Bio-Rad Laboratories, 
Hercules, CA). Cell viability was >85%. UPE and metabolomics measurements were performed at cell passage 
number 28. We have used the experimental design as described previously27, with minor modifications. In brief, 
when the cells were split and adjusted for cell density, 1 µM all-trans retinoic acid (ATRA; 98% grade, catalogue 
number R250, Sigma-Aldrich) was added to the cells in order to induce differentiation via the granulocytic path-
way; control cells received the same volume of vehicle. The cells were then incubated for up to 7 days, and UPE 
and metabolomics experiments were performed on days 2 and 7. Prior to any UPE measurement and/or sample 
collection for metabolomics, the culture medium was replaced with fresh IMDM (without supplementation), and 
the cells were counted. Where indicated, cells were stimulated with phorbol 12-myristate 13-acetate (PMA; 98% 
grade, Sigma-Aldrich) in the presence or absence of diphenyleneiodonium chloride (DPI; Cayman Chemicals, 
Ann Arbor, MI). A small aliquot of the cell suspension was used for UPE measurements. Based on the UPE pro-
file, four time points were used for the metabolomics study; aliquots containing of 12 × 106 cells were used for 
each time point. TP1 samples were collected prior to PMA induction; TP2, TP3, and TP4 samples were collected 
60, 4500, and 9000 seconds, respectively, after PMA induction (see Figure S1).
Ultra-weak photon emission (UPE). UPE was measured using a module H7360-01 photomultiplier tube 
(PMT; Hamamatsu Photonics, Hamamatsu, Japan), which is sensitive to wavelengths of 300–650 nm and has a 
dark count of approximately 13 counts per second. UPE was measured from HL-60 cells suspended in IMDM 
without any supplementation. The cell suspension (3 ml containing 1.5 × 106 cells/ml) was transferred to a small 
Petri dish, which was then placed in the PMT dark chamber at 37 °C. The Petri dish was positioned as close as 
possible to the PMT detector using a sample holder. A background measurement was taken before each sample 
measurement. To stimulate the respiratory burst in cells, PMA was applied at a concentration of 54 nM, and the 
UPE profile was recorded for 9000 seconds. DPI was applied at a concentration of 0.9 µM prior to PMA (54 nM) 
stimulation in independent cell suspensions after which the UPE profile was recorded for 9000 seconds. There was 
a brief delay of approximately 30 seconds between PMA application and the start of the UPE measurement due 
to placing the samples in the PMT dark chamber. Control cells (i.e. cells that were not cultured in ATRA) were 
measured using the same conditions.
Collection, quenching, and extraction of cell pellets and culture medium for metabolom-
ics. Sample collection and quenching. Aliquots of suspension cells were centrifuged for 4 minutes at 0.2 rcf at 
room temperature. The supernatant (containing the culture medium) was collected and stored at −80 °C. The pel-
lets (containing the cells) were quenched in 0.9% (w/v) sodium chloride solution (Sigma-Aldrich) at 0–2 °C. The 
cell aliquots were then centrifuged for 4 minutes at 0.2 rcf at room temperature. The supernatant was discarded, 
and the cell pellets were stored at −80 °C.
Extraction. The medium and cell pellets were extracted using a liquid-liquid extraction protocol as described 
below.
Cell pellets–First, each cell pellet was suspended in 500 µl citric acid (Merck, Darmstadt, Germany), 5 µl anti-
oxidant containing 0.4 mg/ml butylated hydroxytoluene (BHT; Sigma-Aldrich) and 0.4 mg/ml ethylenediamine-
tetraacetic acid (EDTA; Sigma-Aldrich), 10 µl internal standard mix (ISTD) comprised of deuterated compounds 
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(Cayman Chemicals), and 1 ml n-butanol (Boom B.V., Meppel, the Netherlands):ethyl acetate (Biosolve B.V., 
Valkenswaard, the Netherlands). The cell suspension was shaken in a bullet blender (Next Advance, Averill Park, 
NY) to mix the organic phase and lyse the cells. The suspension was then centrifuged for 10 minutes at 16.1 rcf at 
4 °C, and 900 µl of the organic phase was collected from each sample. The remaining mixture was subjected to a 
second extraction round with 400 µl n-butanol (saturated in Milli-Q water from EMD Millipore, Billerica, MA) 
and 400 µl of ethyl acetate. The mixture was then shaken and centrifuged, and 800 µl of the organic phase was 
collected and added to the first-round organic phase sample. Finally, the organic phase was dried in a CentriVap 
centrifugal concentrator. The dried samples were resuspended in 30 µl injection solution consisting of 70% MeOH 
(Biosolve B.V.) in Milli-Q water and transferred to a glass vial suitable for use in the LC system.
Medium samples–Medium samples (800 µl total) were divided into two 400-µl aliquots to increase the concen-
tration of extracellular metabolites. First, we added 400 µl citric acid, 5 µl antioxidant (0.4 mg/ml BHT and 0.4 mg/
ml EDTA), 6 µl ISTD mix, and 1 ml butanol:ethyl acetate to each aliquot. The samples were then shaken using a 
bullet blender, centrifuged for 10 minutes at 16.1 rcf at 4 °C, and 950 µl of the organic phase was collected. The 
remaining mixture was subjected to a second extraction round with 500 µl butanol saturated in Milli-Q water and 
500 µl of ethyl acetate. The mixture was then shaken and centrifuged for 10 minutes at 16.1 rcf at 4 °C; 950 µl of 
the organic phase was collected and added to the first-round organic phase sample. The organic phase was dried 
using a CentriVap centrifugal concentrator. The dried samples were resuspended in 30 µl injection solution (70% 
MeOH in Milli-Q water) and transferred to a glass vial suitable for use in the LC system.
Liquid chromatography–mass spectrometry (LC-MS) analysis. For metabolomics, a model LCMS-8050 liq-
uid chromatograph-mass spectrometer (Shimadzu, Tokyo, Japan) and an ACQUITY BEH C18 column 
(50 mm × 2.1 mm, 1.7 μm; Waters, Milford, MA) maintained at 40 °C was used for reverse-phase LC separation. 
Electrospray ionisation was used as an ionisation source. The mobile phase A consisted of H2O containing 0.1% 
acetic acid. The mobile phase B contained 75% acetonitrile, 25% MeOH, and 0.1% acetic acid (Sigma-Aldrich). 
The mobile phase C contained 100% isopropanol. The temperature of the column was set at 40 °C, and the tem-
perature of the autosampler was set at 5 °C. The injection volume and flow rate were 10 µl and 0.7 ml/min, respec-
tively. After each measurement, peak detection and integration of the raw data were processed and analysed using 
the Shimadzu Lab Solutions software program, version 5.65. Pooled cell pellet extracts and pooled medium sam-
ples were prepared and measured after every ten samples in order to verify reliability of the measurements. Any 
metabolites detected in the pooled samples that exceeded 30% of the relative standard deviation due to technical 
and/or analytical variations were excluded from analysis.
Statistical analysis. UPE data were analysed using GraphPad Prism (GraphPad Software, Inc., La Jolla, 
CA). The two-tailed paired Student’s t-test was used to compare individual groups. The metabolic results (i.e. 
response ratio) were uploaded to the MetaboAnalyst website (http://www.metaboanalyst.ca)63, 64 and tested for 
statistical significance. To obtain data with a normal distribution, the metabolomics data were log-transformed 
and auto-scaled. We analysed the following parameters: (i) the variance between the four time points (i.e. TP1, 
TP2, TP3, and TP4) relative to PMA stimulation was analysed using a two-way ANOVA (two-tailed); (ii)) the 
variance between the four time points in cells treated with DPI and PMA were analysed using a two-way ANOVA 
(two-tailed); and (iii)) Spearman’s correlation coefficient (two-tailed) was used to analyse the relationship 
between the UPE data and metabolic profile. Spearman’s correlations were done independently for the PMA and 
DPI + PMA groups, correlating their averaged metabolite levels to their respective averaged UPE profiles over the 
four TPs measured. Differences with a p-value < 0.05 were considered significant.
References
 1. Babior, B. M. The respiratory burst oxidase. In: Molecular Aspects of Inflammation (Sies, H., Flohe, L., Zimmer, G. Eds). Springer-
Verlag Berlin Heidelberg. 41–47 (1991).
 2. Dahlgren, C. & Karlsson, A. Respiratory burst in human neutrophils. Journal of immunological methods 232, 3–14, doi:10.1016/
S0022-1759(99)00146-5 (1999).
 3. Glass, G. A. et al. The respiratory burst oxidase of human neutrophils. Further studies of the purified enzyme. Journal of Biological 
Chemistry 261, 13247–13251 (1986).
 4. Bylund, J., Björnsdottir, H., Sundqvist, M., Karlsson, A. & Dahlgren, C. Measurement of respiratory burst products, released or 
retained, during activation of professional phagocytes. Neutrophil methods and protocols 1124, 321–338, doi:10.1007/978-1-62703-
845-4 (2014).
 5. Bylund, J., Brown, K. L., Movitz, C., Dahlgren, C. & Karlsson, A. Intracellular generation of superoxide by the phagocyte NADPH 
oxidase: how, where, and what for? Free Radic Biol and Med 49, 1834–1845, doi:10.1016/j.freeradbiomed.2010.09.016 (2010).
 6. Panday, A., Sahoo, M. K., Osorio, D. & Batra, S. NADPH oxidases: an overview from structure to innate immunity-associated 
pathologies. Cell Mol Immunol 12, 5–23, doi:10.1038/cmi.2014.89 (2015).
 7. Babior, B. M. NADPH oxidase: an update. Blood 93, 1464–1476 (1999).
 8. Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 
245–313, doi:10.1152/physrev.00044.2005 (2007).
 9. Ray, P. D., Huang, B. W. & Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 
24, 981–990, doi:10.1016/j.cellsig.2012.01.008 (2012).
 10. Bartsch, H. & Nair, J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, 
DNA damage, and repair. Langenbecks Arch Surg 391, 499–510, doi:10.1007/s00423-006-0073-1 (2006).
 11. Kumar, B., Koul, S., Khandrika, L., Meacham, R. B. & Koul, H. K. Oxidative stress is inherent in prostate cancer cells and is required 
for aggressive phenotype. Cancer Res 68, 1777–1785, doi:10.1158/0008-5472.CAN-07-5259 (2008).
 12. Perry, G., Castellani, R. J., Hirai, K. & Smith, M. A. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. J 
Alzheimers Dis 1, 45–55, doi:10.3233/JAD-1998-1103 (1998).
 13. Sugamura, K. & Keaney, J. F. Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51, 978–992, doi:10.1016/j.
freeradbiomed.2011.05.004 (2011).
 14. Altenhofer, S., Radermacher, K. A., Kleikers, P. W., Wingler, K. & Schmidt, H. H. Evolution of NADPH Oxidase Inhibitors: 
Selectivity and Mechanisms for Target Engagement. Antioxid Redox Signal 23, 406–427, doi:10.1089/ars.2013.5814 (2015).
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 1229  | DOI:10.1038/s41598-017-01229-x
 15. Drummond, G. R., Selemidis, S., Griendling, K. K. & Sobey, C. G. Combating oxidative stress in vascular disease: NADPH oxidases 
as therapeutic targets. Nat Rev Drug Discov 10, 453–471, doi:10.1038/nrd3403 (2011).
 16. Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative stress. Curr Biol 24, R453–462, doi:10.1016/j.
cub.2014.03.034 (2014).
 17. Bylund, J., Bjornsdottir, H., Sundqvist, M., Karlsson, A. & Dahlgren, C. Measurement of respiratory burst products, released or 
retained, during activation of professional phagocytes. Methods Mol Biol 1124, 321–338, doi:10.1007/978-1-62703-845-4_21 (2014).
 18. Prasad, A. & Pospisil, P. Linoleic acid-induced ultra-weak photon emission from Chlamydomonas reinhardtii as a tool for 
monitoring of lipid peroxidation in the cell membranes. PLoS One 6, e22345, doi:10.1371/journal.pone.0022345 (2011).
 19. Rastogi, A. & Pospisil, P. Ultra-weak photon emission as a non-invasive tool for the measurement of oxidative stress induced by UVA 
radiation in Arabidopsis thaliana. J Photochem Photobiol B 123, 59–64, doi:10.1016/j.jphotobiol.2013.03.012 (2013).
 20. Ives, J. A. et al. Ultraweak photon emission as a non-invasive health assessment: a systematic review. PLoS One 9, e87401, 
doi:10.1371/journal.pone.0087401 (2014).
 21. Cifra, M. & Pospisil, P. Ultra-weak photon emission from biological samples: definition, mechanisms, properties, detection and 
applications. J Photochem Photobiol B 139, 2–10, doi:10.1016/j.jphotobiol.2014.02.009 (2014).
 22. Devaraj, B., Usa, M. & Inaba, H. Biophotons: Ultraweak light emission from living systems. Curr Opin Solid St M 2, 188–193, 
doi:10.1016/S1359-0286(97)80064-2 (1997).
 23. Pospisil, P., Prasad, A. & Rac, M. Role of reactive oxygen species in ultra-weak photon emission in biological systems. J Photochem 
Photobiol B 139, 11–23, doi:10.1016/j.jphotobiol.2014.02.008 (2014).
 24. Van Wijk, R., Van Wijk, E. P., Wiegant, F. A. & Ives, J. Free radicals and low-level photon emission in human pathogenesis: state of 
the art. Indian J Exp Biol 46, 273–309 (2008).
 25. Rastogi, A. & Pospisil, P. Spontaneous ultraweak photon emission imaging of oxidative metabolic processes in human skin: effect of 
molecular oxygen and antioxidant defense system. J Biomed Opt 16, 096005, doi:10.1117/1.3616135 (2011).
 26. Burgos, R. C., van Wijk, E. P., van Wijk, R., He, M. & van der Greef, J. Crossing the Boundaries of Our Current Healthcare System 
by Integrating Ultra-Weak Photon Emissions with Metabolomics. Front Physiol 7, 611, doi:10.3389/fphys.2016.00611 (2016).
 27. Burgos, R. C. et al. Tracking biochemical changes correlated with ultra-weak photon emission using metabolomics. J Photochem 
Photobiol B 163, 237–245, doi:10.1016/j.jphotobiol.2016.08.030 (2016).
 28. Galantsev, V. P., Kovalenko, S. G., Moltchanov, A. A. & Prutskov, V. I. Lipid peroxidation, low-level chemiluminescence and 
regulation of secretion in the mammary gland. Experientia 49, 870–875, doi:10.1007/Bf01952600 (1993).
 29. McCarthy, M. K. & Weinberg, J. B. Eicosanoids and respiratory viral infection: coordinators of inflammation and potential 
therapeutic targets. Mediators Inflamm 2012, 236345–13, doi:10.1155/2012/236345 (2012).
 30. Montuschi, P., Barnes, P. J. & Roberts, L. J. 2nd. Isoprostanes: markers and mediators of oxidative stress. FASEB J 18, 1791–1800, 
doi:10.1096/fj.04-2330rev (2004).
 31. Cadenas, E., Boveris, A. & Chance, B. In Free Radicals in Biology 211–242 (Academic Press, 1984).
 32. Cadenas, E. & Sies, H. Formation of electronically excited states during the oxidation of arachidonic acid by prostaglandin 
endoperoxide synthase. Methods Enzymol 319, 67–77, doi:10.1016/S0076-6879(00)19009-3 (2000).
 33. Cadenas, E., Sies, H., Nastainczyk, W. & Ullrich, V. Singlet oxygen formation detected by low-level chemiluminescence during 
enzymatic reduction of prostaglandin G2 to H2. Hoppe Seylers Z Physiol Chem 364, 519–528, doi:10.1515/bchm2.1983.364.1.519 
(1983).
 34. Nakano, M. Low-level chemiluminescence during lipid peroxidations and enzymatic reactions. J Biolumin Chemilumin 4, 231–240, 
doi:10.1002/bio.1170040133 (1989).
 35. Breitman, T. R., Selonick, S. E. & Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by 
retinoic acid. Proc Natl Acad Sci USA 77, 2936–2940, doi:10.1073/pnas.77.5.2936 (1980).
 36. Levy, R., Rotrosen, D., Nagauker, O., Leto, T. L. & Malech, H. L. Induction of the respiratory burst in HL-60 cells. Correlation of 
function and protein expression. J Immunol 145, 2595–2601 (1990).
 37. Fu, J. et al. Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with 
rheumatoid arthritis. Anal Bioanal Chem 408, 6307–6319, doi:10.1007/s00216-016-9742-2 (2016).
 38. Collins, S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70, 
1233–1244 (1987).
 39. Gallagher, R. et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute 
promyelocytic leukemia. Blood 54, 713–733 (1979).
 40. Dang, P. M., Fontayne, A., Hakim, J., El Benna, J. & Perianin, A. Protein kinase C zeta phosphorylates a subset of selective sites of the 
NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol 166, 
1206–1213, doi:10.4049/jimmunol.166.2.1206 (2001).
 41. el Benna, J., Faust, L. P. & Babior, B. M. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil 
activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem 269, 23431–23436 
(1994).
 42. Tardif, M., Rabiet, M. J., Christophe, T., Milcent, M. D. & Boulay, F. Isolation and characterization of a variant HL60 cell line 
defective in the activation of the NADPH oxidase by phorbol myristate acetate. J Immunol 161, 6885–6895 (1998).
 43. Cross, A. R. & Jones, O. T. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. 
Specific labelling of a component polypeptide of the oxidase. Biochem J 237, 111–116, doi:10.1042/bj2370111 (1986).
 44. Hancock, J. T. & Jones, O. T. G. The Inhibition by Diphenyleneiodonium and Its Analogs of Superoxide Generation by Macrophages. 
Biochemical Journal 242, 103–107, doi:10.1042/bj2420103 (1987).
 45. Liu, Y., Fiskum, G. & Schubert, D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 
80, 780–787, doi:10.1046/j.0022-3042.2002.00744.x (2002).
 46. Li, Y. & Trush, M. A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen 
species production. Biochem Bioph Res Co 253, 295–299, doi:10.1006/bbrc.1998.9729 (1998).
 47. Buczynski, M. W., Dumlao, D. S. & Dennis, E. A. Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid 
biology. J Lipid Res 50, 1015–1038, doi:10.1194/jlr.R900004-JLR200 (2009).
 48. Fullerton, J. N., O’Brien, A. J. & Gilroy, D. W. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol 
35, 12–21, doi:10.1016/j.it.2013.10.008 (2014).
 49. Parchmann, S. & Mueller, M. J. Evidence for the Formation of Dinor Isoprostanes E1from α-Linolenic Acid in Plants. J Biol Chem 
273, 32650–32655, doi:10.1074/jbc.273.49.32650 (1998).
 50. Morrow, J. D. et al. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring 
isoprostanes. J Biol Chem 269, 4317–4326 (1994).
 51. Longmire, A. W., Roberts, L. J. & Morrow, J. D. Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/
endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 48, 
247–256, doi:10.1016/0090-6980(94)90011-6 (1994).
 52. Wilson, J. R. & Kapoor, S. C. Contribution of prostaglandins to exercise-induced vasodilation in humans. Am J Physiol 265, 
H171–175 (1993).
 53. Smith, J. B. Prostaglandins and platelet aggregation. Acta Med Scand Suppl 651, 91–99 (1981).
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 1229  | DOI:10.1038/s41598-017-01229-x
 54. Rieser, C., Bock, G., Klocker, H., Bartsch, G. & Thurnher, M. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate 
human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186, 1603–1608, doi:10.1084/jem.186.9.1603 
(1997).
 55. Van Brocklyn, J. R. & Williams, J. B. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine 
kinase: oxidative stress and the seesaw of cell survival and death. Comparative Biochemistry and Physiology Part B: Biochemistry and 
Molecular Biology 163, 26–36, doi:10.1016/j.cbpb.2012.05.006 (2012).
 56. Lambeth, J., Burnham, D. & Tyagi, S. Sphinganine effects on chemoattractant-induced diacylglycerol generation, calcium fluxes, 
superoxide production, and on cell viability in the human neutrophil. Delivery of sphinganine with bovine serum albumin 
minimizes cytotoxicity without affecting inhibition of the respiratory burst. J Biol Chem 263, 3818–3822 (1988).
 57. Hannun, Y. A., Loomis, C. R., Merrill, A. H. Jr. & Bell, R. M. Sphingosine inhibition of protein kinase C activity and of phorbol 
dibutyrate binding in vitro and in human platelets. J Biol Chem 261, 12604–12609 (1986).
 58. Satoshi, K. et al. Effect of sphingosine and its N-methyl derivatives on oxidative burst, phagokinetic activity, and trans-endothelial 
migration of human neutrophils. Biochemical pharmacology 44, 1585–1595, doi:10.1016/0006-2952(92)90476-Y (1992).
 59. Shishikura, K. et al. Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP. British 
Journal of Pharmacology 173, 319–331, doi:10.1111/bph.13373 (2016).
 60. Mitsuyama, T., Takeshige, K. & Minakami, S. Cyclic AMP inhibits the respiratory burst of electropermeabilized human neutrophils 
at a downstream site of protein kinase C. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1177, 167–173, 
doi:10.1016/0167-4889(93)90036-O (1993).
 61. Heinemann, A., Schuligoi, R., Sabroe, I., Hartnell, A. & Peskar, B. A. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin 
D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 170, 4752–4758, 
doi:10.4049/jimmunol.170.9.4752 (2003).
 62. Saito, S., Tsuda, H. & Michimata, T. Prostaglandin D2 and reproduction. Am J Reprod Immunol 47, 295–302, doi:10.1034/j.1600-
0897.2002.01113.x (2002).
 63. Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. & Wishart, D. S. MetaboAnalyst 2.0-a comprehensive server for metabolomic 
data analysis. Nucleic Acids Res 40, W127–133, doi:10.1093/nar/gks374 (2012).
 64. Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res 43, 
W251–257, doi:10.1093/nar/gkv380 (2015).
Acknowledgements
This work was supported by CNPq, the National Council for Scientific and Technological Development – Brazil. 
R.C.R.B. is the recipient of a scholarship from Science without Borders (scholarship number 230827/2012-8). The 
authors thank Dr Slavik Koval for help with statistical analyses.
Author Contributions
R.C.R.B., J.C.S., and L.W. conducted the experiments and analysed the results. K.C. prepared the cell cultures and 
helped write the manuscript. R.C.R.B. and R.B. designed the study. R.C.R.B. and J.C.S. wrote the manuscript. M.C., 
E.W., R.R., J.G., and T.H. supervised the research. All authors reviewed and approved the manuscript. M.C. and K.C. 
acknowledge Czech Science Foundation project GP13-29294S and participate in COST Actions BM1309, CA15211 
and bilateral exchange project between Czech and Slovak Academies of Sciences, no. SAV-15-22.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-01229-x
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
